Listed

Evommune, Inc.

EVMNNYSECIK 2044725HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$34.9m, Q2 FY2026
Net income−$32.2m, Q2 FY2026
Line itemUnitperiod not labelled2024-09-30period not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reported0.0Revenue, period not labelled, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure3.0Revenue, period not labelled, three months to 2025-03-31$3.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure0.0Revenue, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure10.0Revenue, Q3 FY2025, three months to 2025-09-30$10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Research and development$m13.3Research and development, period not labelled, three months to 2024-09-30$13.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure17.8Research and development, period not labelled, three months to 2024-12-31$17.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure14.4Research and development, period not labelled, three months to 2025-03-31$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure19.6Research and development, period not labelled, three months to 2025-06-30$19.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure19.6Research and development, Q3 FY2025, three months to 2025-09-30$19.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure20.4Research and development, Q4 FY2025, three months to 2025-12-31$20.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure17.3Research and development, Q1 FY2026, three months to 2026-03-31$17.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure26.4Research and development, Q2 FY2026, three months to 2026-06-30$26.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Operating income$m(16.5)Operating income, period not labelled, three months to 2024-09-30−$16.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure(21.5)Operating income, period not labelled, three months to 2024-12-31−$21.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure(15.0)Operating income, period not labelled, three months to 2025-03-31−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(23.0)Operating income, period not labelled, three months to 2025-06-30−$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure(13.3)Operating income, Q3 FY2025, three months to 2025-09-30−$13.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure(29.7)Operating income, Q4 FY2025, three months to 2025-12-31−$29.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure(24.0)Operating income, Q1 FY2026, three months to 2026-03-31−$24.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(34.9)Operating income, Q2 FY2026, three months to 2026-06-30−$34.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure0.0Income tax, period not labelled, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, period not labelled, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure0.0Income tax, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-337984. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-337984. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(15.9)Net income, period not labelled, three months to 2024-09-30−$15.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure(20.7)Net income, period not labelled, three months to 2024-12-31−$20.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure(14.6)Net income, period not labelled, three months to 2025-03-31−$14.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(13.6)Net income, period not labelled, three months to 2025-06-30−$13.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure(12.5)Net income, Q3 FY2025, three months to 2025-09-30−$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure(28.3)Net income, Q4 FY2025, three months to 2025-12-31−$28.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure(21.7)Net income, Q1 FY2026, three months to 2026-03-31−$21.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(32.2)Net income, Q2 FY2026, three months to 2026-06-30−$32.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Diluted EPS$ per share(10.47)Diluted EPS, period not labelled, three months to 2024-09-30−$10.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figurenot reported(9.48)Diluted EPS, period not labelled, three months to 2025-03-31−$9.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(8.80)Diluted EPS, period not labelled, three months to 2025-06-30−$8.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure(8.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$8.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figurenot reported(0.64)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(0.89)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Basic EPS$ per share(10.47)Basic EPS, period not labelled, three months to 2024-09-30−$10.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figurenot reported(9.48)Basic EPS, period not labelled, three months to 2025-03-31−$9.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(8.80)Basic EPS, period not labelled, three months to 2025-06-30−$8.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure(8.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$8.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figurenot reported(0.64)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(0.89)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.89 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure

Balance sheet

Cash and equivalents$60.0m, Q2 FY2026
Shareholders' equity$277.6m, Q2 FY2026
Line itemUnitperiod not labelled2023-12-31period not labelled2024-06-30period not labelled2024-09-30period not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reported18.1Cash and equivalents, period not labelled, at 2024-09-30$18.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure16.3Cash and equivalents, period not labelled, at 2024-12-31$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-093932.Report this figure5.7Cash and equivalents, period not labelled, at 2025-03-31$5.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure61.8Cash and equivalents, period not labelled, at 2025-06-30$61.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure26.8Cash and equivalents, Q3 FY2025, at 2025-09-30$26.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure44.1Cash and equivalents, FY2025, at 2025-12-31$44.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure48.3Cash and equivalents, Q1 FY2026, at 2026-03-31$48.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure60.0Cash and equivalents, Q2 FY2026, at 2026-06-30$60.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Current assets$mnot reportednot reportednot reported74.0Current assets, period not labelled, at 2024-12-31$74.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-093932.Report this figurenot reportednot reported81.9Current assets, Q3 FY2025, at 2025-09-30$81.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure153Current assets, FY2025, at 2025-12-31$153.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure216Current assets, Q1 FY2026, at 2026-03-31$215.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure204Current assets, Q2 FY2026, at 2026-06-30$204.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Total assets$mnot reportednot reportednot reported76.1Total assets, period not labelled, at 2024-12-31$76.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-093932.Report this figurenot reportednot reported84.5Total assets, Q3 FY2025, at 2025-09-30$84.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure225Total assets, FY2025, at 2025-12-31$224.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure322Total assets, Q1 FY2026, at 2026-03-31$322.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure302Total assets, Q2 FY2026, at 2026-06-30$301.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Current liabilities$mnot reportednot reportednot reported28.0Current liabilities, period not labelled, at 2024-12-31$28.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-093932.Report this figurenot reportednot reported10.4Current liabilities, Q3 FY2025, at 2025-09-30$10.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure17.9Current liabilities, FY2025, at 2025-12-31$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure10.6Current liabilities, Q1 FY2026, at 2026-03-31$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure17.5Current liabilities, Q2 FY2026, at 2026-06-30$17.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Total liabilities$mnot reportednot reportednot reported28.5Total liabilities, period not labelled, at 2024-12-31$28.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-093932.Report this figurenot reportednot reported10.7Total liabilities, Q3 FY2025, at 2025-09-30$10.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure19.4Total liabilities, FY2025, at 2025-12-31$19.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure17.9Total liabilities, Q1 FY2026, at 2026-03-31$17.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure24.4Total liabilities, Q2 FY2026, at 2026-06-30$24.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure
Shareholders' equity$m(77.7)Shareholders' equity, period not labelled, at 2023-12-31−$77.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-093932.Report this figure(107)Shareholders' equity, period not labelled, at 2024-06-30−$107.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure(123)Shareholders' equity, period not labelled, at 2024-09-30−$122.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure(144)Shareholders' equity, period not labelled, at 2024-12-31−$144.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure(158)Shareholders' equity, period not labelled, at 2025-03-31−$158.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure(171)Shareholders' equity, period not labelled, at 2025-06-30−$171.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure(183)Shareholders' equity, Q3 FY2025, at 2025-09-30−$183.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure206Shareholders' equity, FY2025, at 2025-12-31$205.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure305Shareholders' equity, Q1 FY2026, at 2026-03-31$304.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure278Shareholders' equity, Q2 FY2026, at 2026-06-30$277.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure

Cash flow

Operating cash flow−$20.3m, Q2 FY2026
Capital expenditure$183.0k, Q2 FY2026
Line itemUnitperiod not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(18.5)Operating cash flow, period not labelled, three months to 2024-12-31−$18.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure(23.9)Operating cash flow, period not labelled, three months to 2025-03-31−$23.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(26.2)Operating cash flow, period not labelled, three months to 2025-06-30−$26.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337984. Derived: 6-month figure less the 3-month figure.Report this figure(9.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-11, accession 0001193125-25-315972. Derived: 9-month figure less the 6-month figure.Report this figure(16.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure(27.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$27.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure(20.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$20.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337984. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, period not labelled, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure0.0Capital expenditure, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337984. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$131.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-12-11, accession 0001193125-25-315972. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$104.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-093932. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$83.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$183.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337984. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)36.14m, Q2 FY2026
Line itemUnitperiod not labelled2024-09-30period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.5Diluted shares (weighted), period not labelled, three months to 2024-09-301,520,814 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure1.5Diluted shares (weighted), period not labelled, three months to 2025-03-311,534,965 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure1.5Diluted shares (weighted), period not labelled, three months to 2025-06-301,540,695 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure1.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,545,010 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-12-11, accession 0001193125-25-315972.Report this figure33.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3133,670,148 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211963.Report this figure36.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3036,135,644 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure

Shares outstanding: 36.29mShares outstanding, period not labelled, at 2026-08-0436,292,113 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337984.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.